First Pass

6 stories from 3 sources

Accessible treatments gain evidence, but health risks remain unsettled

Day’s Recap

Supporting Articles

A randomized clinical trial of 399 adults found that fluvoxamine reduced long COVID-related fatigue and improved quality of life versus placebo. The results position a low-cost, widely available antidepressant as a potential treatment option for one of long COVID’s most disabling symptoms.

9:55 PMScienceDaily

A 12-week intermittent fasting program led to weight loss that remained evident one year later. People who restricted eating to an eight-hour window maintained more weight loss than those who kept a longer daily eating schedule, with both early and late windows working and early timing aiding fat-loss preservation.

7:59 AMScienceDaily

Higher consumption of artificial sweeteners was associated with faster declines in memory and thinking in adults, especially among people under 60 or those with diabetes. The highest intake corresponded to cognitive aging about 1.6 years faster than the lowest, though researchers cautioned that causality is not established.

9:55 AMScienceDaily

Other Developments

A curated list of other prominent stories from this day.

A urologist warns that broad testosterone screening in the military could trigger overdiagnosis and treatment of men with borderline or transiently low values. The piece argues that testing without clear clinical indications risks turning a lab number into a readiness and medical liability problem.

5:21 PMStat News

Laos says it cannot confirm what caused a cluster of tourist deaths in 2024 that were widely linked to suspected methanol poisoning. Officials say the country has no evidence of poisoning because autopsies were not performed.

7:10 AMBBC

Primary care physician leaders argue that the U.S. should stop framing payment and workforce choices as a zero-sum fight between primary care and specialty care. They call for policies that strengthen primary care while aligning incentives across the system, alongside related debates such as treating obesity as a disease.

4:30 AMStat News

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!